Literature DB >> 28129519

It Is Time to Stop Using Epirubicin to Treat Any Patient With Gastroesophageal Adenocarcinoma.

Elena Elimova1, Yelena Y Janjigian1, Mary Mulcahy1, Daniel V Catenacci1, Mariela A Blum1, Khaldoun Almhanna1, J Randolph Hecht1, Jaffer A Ajani1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28129519     DOI: 10.1200/JCO.2016.69.7276

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer.

Authors:  Yelena Y Janjigian; Francisco Sanchez-Vega; Philip Jonsson; Walid K Chatila; Jaclyn F Hechtman; Geoffrey Y Ku; Jamie C Riches; Yaelle Tuvy; Ritika Kundra; Nancy Bouvier; Efsevia Vakiani; Jianjiong Gao; Zachary J Heins; Benjamin E Gross; David P Kelsen; Liying Zhang; Vivian E Strong; Mark Schattner; Hans Gerdes; Daniel G Coit; Manjit Bains; Zsofia K Stadler; Valerie W Rusch; David R Jones; Daniela Molena; Jinru Shia; Mark E Robson; Marinela Capanu; Sumit Middha; Ahmet Zehir; David M Hyman; Maurizio Scaltriti; Marc Ladanyi; Neal Rosen; David H Ilson; Michael F Berger; Laura Tang; Barry S Taylor; David B Solit; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2017-11-09       Impact factor: 39.397

2.  FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers: A Phase 2 Nonrandomized Clinical Trial.

Authors:  Haeseong Park; Ramon U Jin; Andrea Wang-Gillam; Rama Suresh; Caron Rigden; Manik Amin; Benjamin R Tan; Katrina S Pedersen; Kian-Huat Lim; Nikolaos A Trikalinos; Abhilasha Acharya; Megan L Copsey; Katherine A Navo; Ashley E Morton; Feng Gao; A Craig Lockhart
Journal:  JAMA Oncol       Date:  2020-08-01       Impact factor: 31.777

Review 3.  Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy.

Authors:  Brian Badgwell; Prajnan Das; Jaffer Ajani
Journal:  J Hematol Oncol       Date:  2017-08-15       Impact factor: 17.388

Review 4.  Recent Developments of Systemic Chemotherapy for Gastric Cancer.

Authors:  Hiroyuki Arai; Takako Eguchi Nakajima
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

Review 5.  Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers.

Authors:  Jose J G Marin; Maria J Monte; Rocio I R Macias; Marta R Romero; Elisa Herraez; Maitane Asensio; Sara Ortiz-Rivero; Candela Cives-Losada; Silvia Di Giacomo; Javier Gonzalez-Gallego; Jose L Mauriz; Thomas Efferth; Oscar Briz
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

6.  Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.

Authors:  Joanna Gotfrit; Rachel Goodwin; Timothy Asmis; Angela J Hyde; Thierry Alcindor; Francine Aubin; Scott Berry; Dominick Bossé; Colin Brown; Ronald Burkes; Margot Burnell; Bruce Colwell; Jessica Corbett; Jeff Craswell; Nathalie Daaboul; Mark Doherty; D A Barry Fleming; Luisa Galvis; Rakesh Goel; Mohammed Harb; Alwin Jeyakumar; Derek Jonker; Erin Kennedy; Michael Lock; Aamer Mahmud; Patrick H McCrea; Vimoj Nair; Rami Nassabein; Carolyn Nessim; Ravi Ramjeesingh; Muhammad Raza; Wissam Saliba; Satareh Samimi; Simron Singh; Stephanie Snow; Mustapha Tehfé; Michael Thirlwell; Mario Valdes; Stephen Welch; Michael Vickers
Journal:  Curr Oncol       Date:  2021-05-26       Impact factor: 3.677

Review 7.  Recent advances in the management of gastric adenocarcinoma patients.

Authors:  Kazuto Harada; Anthony Lopez; Namita Shanbhag; Brian Badgwell; Hideo Baba; Jaffer Ajani
Journal:  F1000Res       Date:  2018-08-30

Review 8.  Recent advances in treating oesophageal cancer.

Authors:  Kazuto Harada; Jane E Rogers; Masaaki Iwatsuki; Kohei Yamashita; Hideo Baba; Jaffer A Ajani
Journal:  F1000Res       Date:  2020-10-01

Review 9.  Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future.

Authors:  Alessandro Parisi; Giampiero Porzio; Corrado Ficorella
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.